Skip to main content
. Author manuscript; available in PMC: 2023 Sep 26.
Published in final edited form as: Immunohorizons. 2023 Jan 1;7(1):41–48. doi: 10.4049/immunohorizons.2200097

Table I. mRNA levels modulated in MNK-3 cells by IL-23 treatment.

Genes that were up- or down-regulated at least 2 -fold with an adjusted p value <0.05

mRNA Log2 fold change Linear fold change P-value BY.p.value
Il2ra 1.62 3.08 1.62E-13 5.83E-10
Odc1 1.63 3.09 1.79E-10 3.22E-07
Gzmb 1.02 2.03 4.21E-10 5.07E-07
Myd88 1.89 3.71 6.11E-09 5.51E-06
Cyp1b1 3.04 8.23 2.66E-08 1.92E-05
Gda 1.02 2.03 3.45E-08 2.07E-05
Stat5a 1.36 2.57 2.58E-07 0.000103
Cyp4a12a 2.71 6.55 3.3E-07 0.000119
Acox1 1.07 2.1 5.34E-07 0.000148
Ptpn5 2.33 5.02 2.07E-05 0.00276
Haao 4.7 26 0.00026 0.0171
Thbs2 3.55 11.7 0.00049 0.0266
Ms4a1 3.92 15.1 0.00051 0.0273
Pklr 1.71 3.26 0.00061 0.0312
Slc16a11 3.04 8.23 0.00064 0.0325
Cd14 2.76 6.79 0.00084 0.0395
Arid2 1.54 2.91 0.00084 0.0395
Cyp4a10 4.14 17.6 0.00096 0.0438
Cacna1a 4.48 22.2 0.00099 0.0438